Evolution of Ischemic Cerebrovascular Disease in patients with Metabolic Syndrome
Abstract
Introduction: Cerebrovascular ischemia represents the highest incidence and prevalence among cerebrovascular diseases. It is frequently associated with Metabolic Syndrome because many risk factors for cerebrovascular ischemia correspond to this entity.
Objective: To determine the relationship between the evolution of the patient with Acute Ischemic Cerebrovascular Disease (AICVD) and the presence of Metabolic Syndrome (MS).
Material and Methods: An analytical prospective study was conducted with a sample of 100 patients, which were divided into two groups: group A, that was composed of patients with Metabolic Syndrome (MS) according to NCEP/ATPIII criteria (The Adult Treatment Panel III of the National Cholesterol Education), and group B that was composed of patients without Metabolic Syndrome. The National Institutes of Health Stroke Scale (NIHSS) was applied in both groups to evaluate the severity and evolution of cerebrovascular disease.
Results: The Male sex (60%), and white people (52%) prevailed in the group with MS, and the mean age was 61,2 years. The main personal pathological antecedents were Arterial hypertension, cardiopathies, and smoking habit. The severity of cerebrovascular disease on admission was worse in group A (mean: 13,2). These patients presented a greater number of neurological complications such as: intracranial hypertension and convulsions (12%); they also presented non-neurological complications such as: bronchopneumonia (40%), and ulcers resulting from time spent on supine position (28%) with a higher risk (OR: 6,2). After discharge from hospital, 36% of patients with MS got worse, according to Scale NIHSS.
Conclusions: The metabolic syndrome is a risk factor that increases the risk of complications in Ischemic Cerebrovascular Disease and worsens its evolution and prognosis.
Keywords: cerebral ischemia, metabolic syndrome (MS), complications, evolution, dyslipidemia, risk factors.
Downloads
References
1. Barragán García N, Masjuan Vallejo J. Enfermedad cerebrovascular: Control global del riesgo cardiometabólico. Ediciones Díaz de Santos, 2012.
2. Lizarzaburu Robles JC. Síndrome metabólico: concepto y aplicación práctica. An. Fac. med. [online]. 2013 [citado 1 Jun 2015]; 74(4):315-320 . Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext HYPERLINK "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832013000400009&lng=es&nrm=iso"&
3. Ramirez V. Efecto de los Factores de Riesgo Aterogénicos en la Enfermedad Cerebrovascular. [citado 1 Jun 2015] En Convención Salud 2015. Disponible en: http://www.convencionsalud2015.sld.cu/index.php/convencionsalud/2015/paper/viewPaper/600
4. Buergo Zuaznábar MA, Fernández Concepción O. Guías de Práctica Clínica Enfermedad Cerebrovascular. La Habana. Editorial Ciencias Médicas. 2009.
5. Ekblom Ö, Ekblom-Bak E, Rosengren A, Hallsten M, Bergström G, Börjesson M. Cardiorespiratory Fitness, Sedentary Behaviour and Physical Activity Are Independently Associated with the Metabolic Syndrome, Results from the SCAPIS Pilot Study. PLoS One. 2015 Jun 29; 10(6):e0131586.
6. Ancheta IB, Tuason T, Levenson J, Ancheta CV, Battie C, Palaniappan L. International Diabetes Federation (IDF), Harmonizing and National Cholesterol Education Program’s Adult Treatment Panel III (NCEP/ATP III) Definition for Metabolic Syndrome: Which of These Criteria Best Captures the Prevalence of Metabolic Syndrome Among Filipino Women?. Global Heart. 2014 [citado 1 Jun 2015]; 1(9):e118-e119. Disponible en: https://www.infona.pl/resource/bwmeta1.element.elsevier-3ca4ed99-0f1c-3e07-b751-ef8a609c8923
7. Hadaegh F, Mohebi R, Cheraghi L, Tohidi M, Sheikholeslami F, Azizi F. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study. Stroke. 2012 Jun [citado 1 Jun 2015]; 43(6):1669-71. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22382161
8. Mankowski RT, Aubertin-Leheudre M, Beavers DP, Botoseneanu A, Strotmeyer E, Anton SD; LIFE Research Group. Sedentary time is associated with the metabolic syndrome in older adults at high risk for mobility limitations - The LIFE Study. ExpGerontol. 2015 Jun 27; S0531-5565(15)30004-8.
9. Romano LM, Salutto VL. Enfermedad cerebrovascular en pacientes muy ancianos: análisis prospectivo basado en un registro de población hospitalaria argentina. [citado 1 Jun 2015] 2014; Disponible en: http://www.sam.org.ar/congreso_nacional_medicina/2007/comunicaciones_libres_premiadas/C-24-03completo.doc
10. Ponce Gutiérrez Y, Ponce González F, Llanes Álvarez C, Pérez Peralta T, Ramos Martín R, NguyenTrong V. El síndrome metabólico como factor de riesgo en la enfermedad cerebrovascular. Hospital Arnaldo Milián. 2011. Ponencia. Congreso Cardiología. Villa Clara. 2012.
11. Lee Y, Lim YH, Shin JH, Park J, Shin J, Kim KS. The Impact of Metabolic Syndrome on Clinical Outcomes AfterEverolimus-Eluting Stent Implantation. Am J Cardiol. 2015 Jun 4; pii: S0002-9149(15):1425-3.
12. González Sotolongo O, Arpa Gámez Á, Hernández Sierra Y. Influencia del síndrome metabólico sobre la evolución de pacientes hospitalizados en salas de Medicina Interna. RevCubMed Mil [revista en la Internet]. 2014 Dic [citado 2015 Jul 08] ; 43(4): 449-458. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext HYPERLINK "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572014000400005&lng=es"& HYPERLINK "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572014000400005&lng=es"pid=S0138-65572014000400005 HYPERLINK "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572014000400005&lng=es"& HYPERLINK "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572014000400005&lng=es"lng=es.
13. Rodríguez Bonet T, Rivas Cartaza JR, Vasallo Comendeiro VJ, Avalos Martin J, Ponce Reines L. Complicaciones cardiovasculares perioperatorias en pacientes portadores de síndrome metabólico. Revista Cubana de Anestesiología y Reanimación. [revista en la Internet]. 2015 Dic [citado 2015 Jul 08]; 14(1): Disponible en: http://www.bvs.sld.cu/revistas/scar/vol14_2_15/scar02215.htm.
14. Orna JA, Arnal LM, Herguedas EM, Julián BB, Córdoba DP. Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2. Revista española de cardiología, 2014 [citado 1 Jun 2015];57(6):507-513.http://www.sciencedirect.com/science/article/pii/S0300893204771419
15. Ekblom Ö, Ekblom-Bak E, Rosengren A, Hallsten M, Bergström G, Börjesson M. Cardiorespiratory Fitness, Sedentary Behaviour and Physical Activity Are Independently Associated with the Metabolic Syndrome, Results from the SCAPIS Pilot Study. PLoS One. 2015 Jun 29; 10(6):e0131586.
16. Li X, Lin L, Lv L, Pang X, Du S, Li Y. U-shaped relationships between sleep duration and metabolic syndrome and metabolic syndrome components in males: a prospective cohort study. Sleep Med. 2015 May 18. pii: S1389-9457(15):744-3.
Download PDF
